RT Journal Article
T1 Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.
A1 Quiroga, Borja
A1 Soler, Maria Jose
A1 Ortiz, Alberto
A1 Orero, Esther
A1 Tejedor, Sandra
A1 Jarava-Mantecon, Carlos Jesus
A1 Gomez-Perez, Virginia Olinda
A1 Marin-Franco, Antonio Jose
A1 Alfaro-Sanchez, Christian
A1 Puerta-Carretero, Marta
A1 Jaldo-Rodriguez, Maria Teresa
A1 Carnerero-Di-Riso, Manuel Antonio
A1 Martinez, Shaira
A1 Caldeon-Gonzalez, Carmen
A1 Cervienka, Michal
A1 Macias-Carmona, Nicolas
A1 Arroyo, David
A1 Perez-Del-Valle, Katia M
A1 de-Arriba, Gabriel
A1 Mazuecos, Auxiliadora
A1 Cazorla, Juan Manuel
A1 Pereira, Monica
A1 Gonzalez-Parra, Emilio
A1 Sanchez-Marquez, Maria Gabriela
A1 Lancho-Novillo, Carolina
A1 Toyos-Ruiz, Carmen
A1 Aguilar-Cervera, Maria Cinta
A1 Muñoz-Ramos, Patricia
A1 Sanchez-Horrillo, Ana
A1 Jimeno-Martin, Isabel
A1 Toapanta, Nestor
A1 Cigarran-Guldris, Secundino
A1 Folgueiras-Lopez, Montserrat
A1 Valero-San-Cecilio, Rosalia
A1 Villacorta-Linaza, Blanca
A1 Minguela-Pesquera, Ignacio
A1 Santana-Estupiñan, Raquel
A1 Zamora, Rocio
A1 Soriano, Sagrario
A1 Muñoz-de-Bustillo, Eduardo
A1 Pizarro-Sanchez, Maria Soledad
A1 Martinez-Puerto, Ana Isabel
A1 Yugueros, Alejandra
A1 Muñiz-Pacios, Laura
A1 Leyva, Alba
A1 Rojas, Jose
A1 Gansevoort, Ron T
A1 de-Sequera, Patricia
K1 COVID-19
K1 SARS-CoV-2
K1 Anti-Spike
K1 Chronic kidney disease
K1 Hemodialysis
K1 Kidney transplantation
K1 Peritoneal dialysis
K1 Vaccination
AB Information on the effect of a third dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in advanced CKD is incomplete (1). We assessed the humoral response up to 6 months after receipt of two or three doses of the SARS-CoV-2 vaccine across the CKD spectrum. SENOVAC is a prospective, multicentric study of cohorts of patients with CKD: kidney transplant, hemodialysis (HD), peritoneal dialysis (PD), and nondialysis CKD (eGFR <30 ml/min per 1.73 m2) (2,3). Patients were vaccinated against SARS-CoV-2 during routine clinical care. Some patients received a third dose of an mRNA vaccine. This depended on the timing of vaccination drives by local health authorities. We assessed anti-Spike antibodies (CLIA, Covid-19 Spike Quantitative Virla IgG Monotest; Vircell SL, Spain) kinetics at a prespecified 6-month time point after completing the original vaccination schedule (2,3). The study was approved by the ethics committee of Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (ISFJD) (February 2021).
PB American Society of Nephrology
YR 2022
FD 2022-05-12
LK http://hdl.handle.net/10668/20489
UL http://hdl.handle.net/10668/20489
LA en
NO Quiroga B, Soler MJ, Ortiz A, Orero E, Tejedor S, Mantecón CJJ, et al. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum. Clin J Am Soc Nephrol. 2022 Jun;17(6):872-876
DS RISalud
RD Aug 18, 2025